[Federal Register Volume 64, Number 95 (Tuesday, May 18, 1999)]
[Notices]
[Pages 26977-26981]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-12532]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention
[Program Announcement 99064]


Racial and Ethnic Approaches to Community Health 2010; (REACH 
2010) Demonstration Projects; Notice of Availability of Funds

    The President has committed the nation to an ambitious goal by the 
year 2010 to eliminate disparities in health status experienced by 
racial and ethnic minority populations in key areas while continuing 
the progress we have achieved in improving the overall health of the 
American people. In support of this effort, the Department of Health 
and Human Services identified six priority areas in which racial and 
ethnic minorities experience serious health disparities: Infant 
Mortality, Deficits in Breast and Cervical Cancer Screening and 
Management, Cardiovascular Diseases, Diabetes, Human Immunodeficiency 
Virus(HIV)Infections/Acquired Immunodeficiency Syndrome(AIDS), and 
Deficits in Child and/or Adult Immunizations. On behalf of the DHHS-
wide collaborative effort, the Centers for Disease Control and 
Prevention (CDC) will coordinate and manage a major component of 
activities to support this initiative; this component is composed of 
community based demonstration projects to address the six identified 
priority areas of health disparities.
    CDC is committed to achieving the health promotion and disease 
prevention objectives of the Department of Health and Human Services' 
Initiative to Eliminate Racial and Ethnic Health Disparities, Healthy 
People 2000, a nationwide strategy to reduce morbidity and mortality 
and improve the quality of life. This announcement relates to the 
Healthy People 2000 focus areas of Maternal and Infant Health, Diabetes 
and Chronic Disabling Conditions, Heart Disease and Stroke, HIV 
Infection, Cancer, and Immunization and Infectious Diseases.

A. Purpose

    CDC announces the availability of fiscal year (FY) 1999 funds for a 
cooperative agreement program for organizations serving racial and 
ethnic minority populations at increased risk for infant mortality, 
diabetes, cardiovascular diseases, HIV infection/AIDS, deficits in 
breast and cervical cancer screening and management, or deficits in 
child and/or adult immunization rates.

    Note: There will be a video-conference Pre-Application Workshop 
on Friday, May 28, 1999. For more information, contact Letitia 
Presley-Cantrell at (770) 488-5426 or E-mail [email protected]

    The Racial and Ethnic Approaches to Community Health 2010 (REACH 
2010) Demonstration Projects are two-phase projects whose purpose is 
for communities to mobilize and organize their resources in support of 
effective and sustainable programs which will eliminate the health 
disparities of racial and ethnic minorities. These demonstrations 
require but are not limited to collaboration of experts in developing 
and managing health promotion programs and experts in conducting 
health-related research. Such collaboration is needed in order to 
identify and/or develop successful community-based disease prevention 
and health promotion models that can be replicated for the ultimate 
goal of eliminating health disparities among racial and ethnic 
minorities.
    The REACH 2010 Demonstration Projects will examine science-based 
community level interventions which could be effective in eliminating 
health disparities, with the goal of replicating their successes in 
other communities.
    Phase I is a 12-month planning Phase to organize and prepare 
infrastructure for Phase II. Cooperative agreements in Phase I will 
support the planning and development of demonstration programs using a 
collaborative multi-agency and community participation model. Phase I 
may also include the development of baseline measures for assessing the 
outcomes of the projects. Upon completion of Phase I, grantees will 
have utilized appropriate data and developed a Community Action Plan 
(CAP) designed to reduce the level of disparity within the selected 
communities in one or more of the six priority areas of infant 
mortality, diabetes, cardiovascular diseases, HIV infection/AIDS, 
deficits in breast and cervical cancer screening and management, or 
deficits in child and/or adult immunization rates. Please note that 
applications addressing related priority areas (e.g. diabetes and 
cardiovascular diseases, HIV infection/AIDS and infant mortality) will 
be considered.
    Phase II is the implementation of a demonstration project of 
specified interventions for specified priority area(s), for a well 
defined minority population. Phase II also involves appropriate 
evaluations of interventions and outcomes of the project.

B. Eligible Applicants

    Applications may be submitted by public and private nonprofit 
organizations and by governments and their agencies; that is, 
universities, colleges, research institutions, hospitals, other public 
and private nonprofit organizations, State and local governments or 
their bona fide agents, federally recognized Indian tribal governments 
as well as non-federally recognized tribes and other organizations that 
qualify under the Indian Civil Rights Act, State Charter Tribes, Urban 
Indian Health Programs, Indian Health Boards, and Inter-Tribal 
Councils.

Minimal Requirements

1. Proposal
    The Applicant must target one or more specific racial or ethnic 
minority communities that is African American, American Indian or 
Alaska Native, Hispanic American, Asian American, or Pacific Islander. 
Communities or groups which cannot be specified under these categories 
will not be considered.

[[Page 26978]]

2. Lead organization (CCO)
    The applicant must be the lead organization, or Central 
Coordinating Organization (CCO), for a community coalition to focus on 
minority health concerns. The applicant must have at least two years of 
such relevant experience within the past four years. The CCO must have 
direct fiduciary responsibility over the administration and management 
of the project. All applicants must include proof of collaborative 
relationships with at least three (3) other organizations (see 
requirements for Coalition Membership below) as evidenced by a detailed 
(delineating responsibilities and budgetary support) and signed 
Memoranda of Agreements (or other official documentation) among the 
participants. The rationale for selection of the lead organization 
should be included.
3. Coalition Membership
    Coalitions (including the CCO) must have at a minimum a community-
based organization and three other organizations, of which at least one 
must be either:
    a. local or state health department, or
    b. university of research organization.
    The applicant must be able to show strong representation by the 
minority community in the coalition.
4. Tax-exempt status
    For those applicants applying as a private, nonprofit organization, 
proof of tax-exempt status must be provided with the application. Tax-
exempt status is determined by the Internal Revenue Service (IRS) Code, 
Section 501(c)(3). Any of the following is acceptable evidence:
    a. A reference to the organization's listing in the IRS's most 
recent list of tax-exempt organizations described in section 501(c)(3) 
of the IRS Code.
    b. A copy of a currently valid IRS tax-exemption certificate.
    c. A statement from a state taxing body, State Attorney General, or 
other appropriate state official certifying that the applicant 
organization has a nonprofit status and that none of the net earnings 
accrue to any private shareholders or individuals.
    d. A certified copy of the organization's certificate of 
incorporation or similar document if it clearly establishes the 
nonprofit status of the organization.

    Note: Public Law 104-65 states that an organization described in 
section 501(c)(4) of the Internal Revenue Code of 1986 that engages 
in lobbying activities is not eligible to receive Federal funds 
constituting an award, grant, cooperative agreement, contract, loan, 
or any other form.

C. Availability of Funds

    In FY 1999, CDC expects to provide approximately $9,400,000 for 
funding approximately 30 Phase I cooperative agreements. It is expected 
that the average award will be $250,000, with awards ranging from 
$200,000 to $300,000. It is expected that the awards will begin on or 
about September 30, 1999 and will be made for a 12 month budget period.
    Only applicants selected for Phase I will be eligible to compete 
for additional funds to implement and evaluate the demonstration 
program of Phase II. Phase I recipients which successfully compete for 
Phase II awards may anticipate an additional four years of funding (for 
a total project period of five (5) years for Phase I and Phase II). 
Funding estimates, and continuation of awards, may change based on the 
availability of funds.
    Approximately $30 million may be available to fund approximately 
15-20 Phase II cooperative agreements. Criteria for selection of Phase 
II grantees are:
    1. Extent to which Phase I requirements were met.
    2. Appropriate definition of the level of health disparity among 
the target population and the extent of the disparity.
    3. Potential for proposed interventions to affect the priority 
area(s).
    4. Extent of inclusion of community participants and partners. 
Awardee will specifically be evaluated on their ability to recruit and 
maintain appropriate community and public/private collaborators.
    5. The potential for community action plans to assure 
sustainability of the effort.
    6. The potential for the community action plans to leverage 
additional public and/or private resources to support the overall 
prevention effort.
    7. The appropriateness and thoroughness of the evaluation process 
to assess the impact and effectiveness of the project intervention in 
the community.
    8. The appropriateness and thoroughness of the data collection 
infrastructure that is planned for and developed for the demonstration 
project.
    Should additional funding become available in the future, grantees 
funded under Phase I, but not funded for Phase II, will receive 
preference for funding.

Use of Funds

    Under this program announcement, funds may not be used for research 
involving human subjects until Institutional Review Board (IRB) 
approval is obtained. Funds may be restricted until appropriate IRB 
clearances and procedures are in place.
    Funds may be used for priority areas only. However, this does not 
restrict the applicant from documenting the association of underlying 
causes and relationship to priority areas.
    Funds may not be used to support direct patient medical care, or 
facilities construction in Phase I or Phase II, or to supplant or 
duplicate existing funding.
    Although applicants may contract with other organizations under 
these cooperative agreements, applicants must perform a substantial 
portion of the activities (including program management and operations) 
for which funds are requested.

Funding Preferences

    Geographic distribution among communities across the United States, 
diversity in priority areas, and racial/ethnic diversity will be 
funding considerations.
    Each applicant may submit only one application, and our intent is 
to fund one award per community; therefore, applicants from the same 
geographic area are encouraged to collaborate. Applicants must describe 
the geographic boundaries and make-up of the area for which it is 
applying. A community will not be eligible for multiple awards for 
different priority areas. However, applications addressing related 
priority areas (e.g. diabetes and cardiovascular diseases, HIV 
infection/AIDS and infant mortality) will be considered.

D. Program Requirements

    In conducting activities to achieve the purposes of this program, 
the recipient will be responsible for the activities under 1. Recipient 
Activities, and CDC will be responsible for the activities under 2. CDC 
Activities:
1. Recipient Activities--Phase I
    a. Enhance community coalition by identifying all appropriate 
additional partners, including community-based organizations, academic, 
foundations, State and local health agencies, Indian Health Boards, 
NRMOs, etc., from which to strengthen the community's overall ability 
to eliminate the health disparities of the target population, and to 
demonstrate the changes in health disparities. The applicant must be 
able to show strong representation by the targeted minority community 
in the coalition.
    b. Establish community working groups to address critical program

[[Page 26979]]

issues, and enhance local partnerships to strengthen the overall 
commitment of the community. Establish linkages with national and state 
partners (governmental and non-governmental) and other interested 
organizations.
    c. Coordinate and use relevant data and community input to assess 
the extent of the problem in the selected program priority areas 
(infant mortality, diabetes, cardiovascular diseases, HIV infection/
AIDS, deficits in breast and cervical cancer screening and management, 
or deficits in child and/or adult immunization rates).
    d. Select intervention strategies which have the most promising 
potential for reducing the health disparities of the target population. 
Develop a Community Action Plan reflecting the intervention strategies, 
and other activities proposed for Phase II.
    e. Identify data sources and establish outcome and process 
evaluation measures to be reviewed at the completion of Phase I. 
(Examples of possible performance measures are provided in the 
Addendum). Collaborate with CDC, academic partners or other appropriate 
organizations, to determine an appropriate evaluation of the program 
and to identify promising intervention strategies for Phase II.
    f. Participate in up to 3 CDC sponsored workshops for technical 
assistance, planning, evaluation and other essential programmatic 
issues.
Phase II:
    a. Implement the community action plan addressing the selected 
priority area(s) for the target population. Initiate actions to assure 
the interventions are administered effectively, appropriately and in a 
timely manner.
    b. Collect appropriate data to monitor and evaluate the program 
including process and outcome measures.
    c. Maintain linkages and collaborations with local partners, and 
develop new linkages with state and national partners.
    d. Collaborate with academic or other appropriate institutions in 
the analysis and interpretation of the data.
    e. Establish mechanisms with other public and/or private groups to 
maintain financial support for the program at the conclusion of federal 
support.
    f. Participate in conferences and workshops to inform and educate 
others regarding the experiences and lessons learned from the project, 
and collaborate with appropriate partners to publish the results of the 
project to the public health community.
2. CDC Activities
    a. Provide consultation and technical assistance in the planning 
and evaluation of program activities.
    b. Provide up-to-date scientific information on the basic 
epidemiology of the priority area(s), recommendations on promising 
intervention strategies, and other pertinent data and information needs 
for the specified priority area(s) including prevention measures and 
program strategies.
    c. Assist in the analysis of data and evaluation of program 
progress.
    d. Assist recipients in collaborating with State and local health 
departments, community planning groups, foundations and other funding 
institutions, and other potential partners.
    e. Foster the transfer of successful prevention interventions and 
program models through convening meetings of grantees, workshops, 
conferences, and communications with project officers.

E. Application Content

    Each applicant may submit only one application. Applicants should 
use the information in the Program Requirements, Other Requirements, 
and Evaluation Criteria sections to develop the application content. 
Applications will be evaluated on the criteria listed, so it is 
important to follow them in laying out the program plan. In developing 
this plan, applicants must describe a community-based program within at 
least one of the six following priority areas: (1) Infant mortality, 
(2) diabetes, (3) cardiovascular diseases, (4) HIV infection/AIDS, (5) 
deficits in breast and cervical cancer screening and management, or (6) 
deficits in child and/or adult immunizations, that specifically focus 
on a geographically defined racial or ethnic minority community that is 
African American, American Indian, Alaska Native, Hispanic American, 
Asian American, or Pacific Islander.
    The narrative should be no more than 30 double-spaced pages, 
printed on one side, with one inch margins, and 12 point font. The 
thirty pages does not include budget, appended pages, or items placed 
in appended pages (resumes, agency descriptions, etc.). The narrative 
should include:
1. One Page Abstract
    Describe:
    a. the Central Coordinating Organization (type of organization and 
relevant experience);
    b. membership in the coalition (types of organizations as specified 
in ``Eligible Applicants'' Section;
    c. target racial/ethnic minority population(s) to be served; and
    d. health priority area(s) to be addressed.
2. Introduction
    A brief summary of which geographically defined racial or ethnic 
group or groups the applicant will target, the population size of both 
the ethnic or racial group(s) and total population of the catchment 
area of the applicant and its partners, the geographic boundaries in 
which the applicant will operate (append a legible map to the 
application) and the priority area(s) chosen for the proposal. The 
enclosed Addendum includes a table that provides sample sizes that 
could be needed to demonstrate a statistically significant intervention 
effect. Based on this table, it has been calculated that a minimum of 
3000 persons with the disease or health priority condition per 
community will be necessary to find statistically significant results. 
Since many of the communities may have considerably smaller sample 
sizes, for the purpose of this announcement, a target population size 
of 3000 is desirable but not mandatory. Applicants are encouraged to 
include as large a population as possible in order to find 
statistically significant results once an intervention is selected.
3. Community Need and Priority Area(s)
    A description of the specific community's health problem and need 
for the priority area(s) for which the applicant will address. Any data 
in support of the priority area(s) and which defines the degree of 
disparity in terms of mortality or morbidity (or other measures 
appropriate to the priority area(s). All sources of data and 
information must be referenced.
4. Organizational Summary (CCO and Coalition Members)
    A brief organizational summary of the CCO including mission 
statement, history of incorporation, and experience in community-based 
work. Relevant supporting documents (including resumes and job 
descriptions of participating staff) should be appended to the 
application, but should not be included in this summary.
    A brief history of the CCO's experience in operating and centrally 
administering a coordinated public health or related program serving 
the proposed and geographically defined racial or ethnic minority 
populations (including program data collection and interventions for 
one or more of the six (6) priority areas). Applicant must have at 
least two years of such relevant

[[Page 26980]]

experience within the past four years. Applicants should describe the 
extent to which racial and ethnic minorities are represented on 
governing boards and in key leadership positions. Applicants should 
provide descriptions of two years of other collaborative ventures 
within the past four years and document: (a) the accomplishments of 
those collaborative ventures, and (b) the characteristics that led to 
the accomplishments. Applicant must describe nature of coalition and 
members of coalition by type of organization and relevant 
organizational experience. The applicant must be able to show strong 
representation by the targeted minority community in the coalition. 
Signed Memoranda of Agreement (or other official documentation) of the 
relevant collaboration should be appended to the document, but not 
included in this section of the narrative. Tribal resolution(s) or 
letter(s) of support from tribal chair(s) or president(s) should be 
appended to this section of the document for those applicants applying 
as tribes.
5. History and experience in working with ethnic/racial groups
    Succinctly describe your experience working directly with the 
target population for at least two years in the selected communities 
during the past four years. Applicants should also explain their 
current relationship with the target population. Any other related 
experience in which the applicant was involved but not the lead 
organization, but which is specific to the target population should 
also be included. Letters of support, awards, newspaper articles, 
evaluation reports, and other forms of recognition which validate 
statements and past efforts should be appended to the application.
6. Community Action Plan
    A description of plans for developing and organizing the planning 
effort, to include who is or should partner in the effort, how 
community participation will be obtained, how the applicant anticipates 
enhancing the sustainability of the effort, including improving 
linkages with collaborators and other organizations to leverage more 
resources (such as foundations, health departments, and other 
potentially influential and beneficial groups), how the applicant will 
collect data and information to track progress towards project goals of 
decreasing disparities. Letters of support from agencies, institutions, 
and other potential collaborators as well as any examples of previous 
planning documents should be appended to the application.
7. Evaluation Plan
    A description of the evaluation and monitoring process that the 
applicant will use to track and measure progress in Phase I. The 
evaluation plan should include time-specific objectives which account 
for the major activities of the community action plan, the means of 
tracking and measuring the collaborative work with coalition partners, 
and any other relevant process measures. Time lines, objectives, and 
other supporting documentation should be included in the appendix for 
this section.
8. Budget
    Provide a line-item budget with a detailed, narrative justification 
that is consistent with the purpose and objectives of this cooperative 
agreement.
9. Human Subjects
    Adequately address the requirements of Title 45 CFR Part 46 for the 
protection of human subjects.

F. Submission and Deadline

    Letter of Intent (LOI) Organizations intending to apply are 
encouraged to submit a non-binding letter of intent to the address 
below. Your letter of intent should include the following information:
    1. Identify the project by name and announcement number 99064.
    2. Identify the geographic location, health priority area(s), and 
racial/ethnic group which the application will address.
    3. Identify Central Coordinating Organization (CCO) and Coalition 
Members.
    This process will enable CDC to plan more efficiently for the 
processing and review of the applications.
    Please submit the letter of intent to the address below on or 
before June 1, 1999.

Send the letter to: Adrienne S. Brown, Grants Management Specialist, 
Grants Management Branch, Procurement and Grants Office, Announcement 
99064, Centers for Disease Control and Prevention (CDC), 2920 
Brandywine Road, Room 3000, Atlanta, Georgia 30341-4146,
      or
E-mail: [email protected]

Application: Submit the original and five copies of PHS-398 (OMB Number 
0925-0001) (adhere to the instructions on the Errata Instruction Sheet 
for PHS 398). Forms are in the application kit. Submit the application 
on or before June 30, 1999, to the business management contact listed 
in Section J., ``Where to Obtain Additional Information.''

Deadline: Applications shall be considered as meeting the deadline if 
they are either:

    (a) Received on or before the deadline date; or
    (b) Sent on or before the deadline with a legibly dated U.S. Postal 
Service postmark or obtain a legibly dated receipt from a commercial 
carrier or U.S. Postal Service. Private metered postmarks shall not be 
acceptable as proof of timely mailing.

Late Applications: Applications which do not meet the criteria in (a) 
or (b) above are considered late applications, will not be considered, 
and will be returned to the applicant.

G. Evaluation Criteria (100 points)

    Each application will be evaluated individually against the 
following criteria by an independent review group appointed by CDC.
1. Background on Community and Priority Area(s): (25 Points)
    a. The extent to which the applicant clearly defines the racial/
ethnic group(s), geographic community, and priority area(s) to be 
addressed.
    b. The extent to which the applicant uses data if such data are 
available and other supporting evidence to document the disparities 
within the group, and the appropriateness of the target population 
sizes (see addendum) for the priority area(s) selected. The enclosed 
Addendum includes a table that provides sample sizes that could be 
needed to demonstrate a statistically significant intervention effect. 
Based on this table, it has been calculated that a minimum of 3000 
persons with the disease or health priority condition per community 
will be necessary to find statistically significant results. Since many 
of the communities may have considerably smaller sample sizes, for the 
purpose of this announcement, a target population size of 3000 is 
desirable but not mandatory. Applicants are encouraged to include as 
large a population as possible in order to find statistically 
significant results once an intervention is selected.
    c. The degree of the disparity between the target population and 
the general population based on local data wherever available, or from 
State or national level

[[Page 26981]]

data which directly supports the basis for the health disparity in the 
priority area(s) selected.
2. Organizational Summary: (20 Points)
    a. Extent to which applicant describes the history, nature, and 
extent of its relevant experience in organizing community activities 
and details at least two years of relevant experience within that past 
four years with supporting documentation.
    b. Extent to which the applicant describes existing facilities and 
staff (including resumes and job descriptions) to accomplish the 
desired outcomes of Phase I.
    c. The adequacy of proposed staffing and collaborations with 
partners, particularly to meet the design and evaluation needs of the 
project. Include the nature of coalition and members of coalition by 
type of organization and relevant organizational experience. The 
applicant must show strong representation by the minority community in 
the coalition.
3. History and Experience in working on public health programs with 
Ethnic/Racial Groups: (25 Points)
    a. Extent to which the applicant documents its experience and 
successes in operating and centrally administering a coordinated public 
health or related program serving the target population for at least 
two years (within the past four years) for the selected priority 
area(s) (including appended letters of support).
    b. Extent of experience in other public health programs, and public 
health research or related data collection.
4. Community Action Plan (CAP): (20 Points)
    Extent to which the applicant demonstrates a thorough and 
reasonable plan for the development of their CAP, including the 
assurance of community participation and participation of coalition 
members in the planning of the CAP.
5. Evaluation plan: (10 points)
    a. Extent to which the applicant presents a reasonable and thorough 
evaluation plan for Phase I.
    b. Appropriateness of evaluation methods, goals, objectives, and 
time lines to the development of the community action plan and the 
overall planning effort, and identification of data and information 
sources needed to track progress toward the project's objectives.
6. Budget (Not Scored)
    Extent to which a line-item budget is presented, justified, and is 
consistent with the purposes and objectives of the cooperative 
agreement.
7. Human Subjects (Not Scored)
    Does the application include a plan to adequately address the 
requirements of Title 45 CFR Part 46 for the protection of human 
subjects?

H. Other Requirements

    Technical Reporting Requirements--Provide CDC with original plus 
two copies of
    1. progress reports semiannually;
    2. financial status report, no more than 90 days after the end of 
the budget period; and
    3. final financial status and performance reports, no more than 90 
days after the end of the project period.
    Send all reports to the business management contact listed in 
Section J., ``Where to Obtain Additional Information.''
    The following additional requirements are applicable to this 
program. For a complete description of each, see Attachment I in the 
application kit.

    AR-1  Human Subjects Requirements
    AR-2  Requirements for Inclusion of Women and Racial and Ethnic 
Minorities in Research
    AR-4  HIV/AIDS Confidentiality Provisions
    AR-5  HIV Program Review Panel Requirements
    AR-7  Executive Order 12372 Review
    AR-8  Public Health System Reporting Requirements
    AR-9  Paperwork Reduction Act Requirements
    AR-10  Smoke-Free Workplace Requirements
    AR-11  Healthy People 2000
    AR-12  Lobbying Restrictions
    AR-14  Accounting System Requirements
    AR-15  Proof of Non-Profit Status

I. Authority and Catalog of Federal Domestic Assistance (CFDA) 
Number

    This program is authorized under sections 301(a) and 317(k)(2) of 
the Public Health Service Act [42 U.S.C. 241(a)and 247b(k)(2)], as 
amended. The Catalog of Federal Domestic Assistance number is 93.945.

J. Where To Obtain Additional Information

    To receive additional written information and to request an 
application kit, call 1-888-GRANTS4 (1-888-472-6874). You will be asked 
to leave your name and address and will be instructed to identify the 
Program Announcement Number 99064.
    If you have questions after reviewing the contents of all the 
documents, business management technical assistance may be obtained 
from: Adrienne S. Brown, Grants Management Specialist, Grants 
Management Branch, Procurement and Grants Office, Announcement 99064, 
Centers for Disease Control and Prevention (CDC), 2920 Brandywine Road, 
Room 3000, Atlanta, GA 30341-4146, Telephone: (770) 488-2755, E-mail: 
[email protected]
    For this and other CDC announcements, see the CDC home page on the 
Internet: http://www.cdc.gov
    For program technical assistance, contact: Letitia Presley-
Cantrell, Centers for Disease Control and Prevention (CDC), National 
Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), 
4770 Buford Hwy, NE, Mailstop K-30, Atlanta, Georgia 30341, Telephone: 
(770) 488-5426, E-mail: [email protected]

    Dated: May 12, 1999.
Henry S. Cassell,
Acting Director, Procurement and Grants Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 99-12532 Filed 5-17-99; 8:45 am]
BILLING CODE 4163-18-P